Lite Strategy, Inc. vs LeonaBio, Inc. — Valuation Comparison 2026
Access all valuation models for LITS vs LONA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.
Access Full Analysis — From $27/mo →LITS scores higher with a 6.5/10 quality rating vs LONA's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
Comparing Lite Strategy, Inc. (LITS) and LeonaBio, Inc. (LONA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.
LITS currently trades at $1.02 with a QOC of 6.5/10, while LONA trades at $9.64 with a QOC of 4.7/10.
Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).